Delivery Order SPE2DB20D1004-SPE2DB25FNLBX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 100 with a ceiling value of $1,167.36. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is scheduled for completion by September 17, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This contract, valued at $22,252.80 with firm fixed pricing, is scheduled for completion by September 19, 2025, and represents a non-set-aside, competitively awarded procurement. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Potassium Chloride Extended Release 8 MEQ tablets in quantities of 500 units, with a contract ceiling value of $7,195.15. This is a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Potassium Chloride Extended Release 20 MEQ tablets in quantities of 1,000 units. This firm fixed-price delivery order, valued at $47,517.99, represents a non-competitive, non-set-aside award with an ultimate completion date of September 9, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units, with a ceiling value of $5,993.44. This is a firm fixed price delivery order with an ultimate completion date of June 20, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Potassium Chloride Extended Release 8 MEQ tablets (500-count packages) with a ceiling value of $4,774.04. This is a firm fixed-price delivery order with an ultimate completion date of June 17, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Potassium Chloride Extended Release 8 milliequivalent tablets in quantities of 500 units. This firm fixed price delivery order, valued at $6,588.65, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement supporting global pharmaceutical procurement for military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Potassium Chloride Extended Release 10 milliequivalent capsules in quantities of 500, with a ceiling value of $1,146.60. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a delivery order valued at $2,476.56 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This contract represents a firm fixed-price delivery order with no set-aside designation, issued competitively on August 5, 2025, with an ultimate completion date of August 6, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units, with a ceiling value of $1,754.24. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 12, 2025, and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The award represents a continuation of the...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNLBXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Potassium Chloride Extended Release 10 milliequivalent tablets in quantities of 100 units, with a contract ceiling value of $2,303.04. This is a firm fixed price delivery order with an ultimate completion date of September 29, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 million and extends through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen delivers a comprehensive portfolio of pharmaceutical products and medical supplies to support military and federal healthcare systems. The company's contract awards demonstrate consistent capability to fulfill federal medical procurement requirements across multiple therapeutic domains, including specialty medications, generic drugs, and critical medical commodities supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/26/25 |